Is it possible to address the needs of employers and employees alike – particularly amid persistent uncertainty about future economic conditions and the market power of workers?
Read More
Osteoarthritis (OA) of the knee is the most common form of arthritis, affecting 30 million Americans and 500 million globally. There are currently no drugs or other treatments available for OA.
Read More
Researchers at RTI International and the University of North Carolina at Chapel Hill launched a new smartphone app this month.
Read More
UNC-Chapel Hill and Duke identify an antibody that blocks infections and minimizes symptoms against a broad array of coronaviruses.
Read More
Hyejung Won, PhD, is principal investigator of five-year project, part of the NIH’s $185-million Impact of Genomic Variation on Function consortium. UNC’s Karen Mohlke, PhD, and Michael Love, PhD, are co-investigators.
Read More
UNC-Chapel Hill and Town of Chapel Hill leaders announce a new university partnership with startup co-working pioneer BioLabs, downtown beautification initiatives, next steps for an innovation hub space, and plans for a downtown innovation district.
Read More
SAS is partnering with researchers at UNC-Chapel Hill to prepare to prevent future infectious diseases from turning into a pandemic like COVID-19, the organizations announced this week.
Read More
Researchers at Duke University and the University of North Carolina at Chapel Hill will jointly form an Alzheimer’s Disease Research Center, one of 33 in the United States, with funding through the National Institutes of Health.
Read More
With more than 1.5 million people in the U.S. diagnosed with cancer in 2019 alone, Chad Pecot is determined to make a lasting impact on the lives of those going through treatment. An associate professor and associate director of translational thoracic oncology at the UNC Lineberger Comprehensive Cancer Center, Pecot – a...
Read More
